178 related articles for article (PubMed ID: 21970487)
1. Liver biopsies in chronic viral hepatitis: beyond grading and staging.
Hudacko R; Theise N
Arch Pathol Lab Med; 2011 Oct; 135(10):1320-8. PubMed ID: 21970487
[TBL] [Abstract][Full Text] [Related]
2. Non-viral-related pathologic findings in liver needle biopsy specimens from patients with chronic viral hepatitis.
Nair V; Fischer SE; Adeyi OA
Am J Clin Pathol; 2010 Jan; 133(1):127-32. PubMed ID: 20023268
[TBL] [Abstract][Full Text] [Related]
3. Liver pathology in obesity.
Suriawinata A; Fiel MI
Semin Liver Dis; 2004 Nov; 24(4):363-70. PubMed ID: 15605304
[TBL] [Abstract][Full Text] [Related]
4. Assessment of liver fibrosis in co-infected patients.
Kelleher TB; Afdhal N
J Hepatol; 2006; 44(1 Suppl):S126-31. PubMed ID: 16352364
[TBL] [Abstract][Full Text] [Related]
5. Liver cell dysplasia and hepatocellular carcinoma in non-A, non-B hepatitis.
Lefkowitch JH; Apfelbaum TF
Arch Pathol Lab Med; 1987 Feb; 111(2):170-3. PubMed ID: 3028314
[TBL] [Abstract][Full Text] [Related]
6. Histopathology of chronic viral hepatitis: guidelines for a revised classification.
Callea F; Baronchelli C; Rodolfi A; Bonetti MF; Brisigotti M
Ital J Gastroenterol; 1995 Apr; 27(3):137-40. PubMed ID: 7548923
[TBL] [Abstract][Full Text] [Related]
7. Chronic viral hepatitis: the histology report.
Guido M; Mangia A; Faa G; ;
Dig Liver Dis; 2011 Mar; 43 Suppl 4():S331-43. PubMed ID: 21459339
[TBL] [Abstract][Full Text] [Related]
8. [Liver biopsy: Which role in patient management?].
Scoazec JY
Ann Pathol; 2010 Dec; 30(6):464-9. PubMed ID: 21167433
[TBL] [Abstract][Full Text] [Related]
9. Concerning particularly delta agent infection, chronic hepatitis, and relation of hepatitis B infection to hepato-cellular carcinoma.
Popper H
Prog Clin Biol Res; 1983; 143():397-410. PubMed ID: 6322201
[No Abstract] [Full Text] [Related]
10. Histopathologic findings in chronic hepatitis C.
Fischer HP; Willsch E; Bierhoff E; Pfeifer U
J Hepatol; 1996; 24(2 Suppl):35-42. PubMed ID: 8836887
[TBL] [Abstract][Full Text] [Related]
11. Hepatic steatosis and the risk of hepatocellular carcinoma in chronic hepatitis C.
Kumar D; Farrell GC; Kench J; George J
J Gastroenterol Hepatol; 2005 Sep; 20(9):1395-400. PubMed ID: 16105127
[TBL] [Abstract][Full Text] [Related]
12. [Pathogenesis and pathomorphology of chronic viral hepatitis].
Longerich T; Bartenschlager R; Schirmacher P
Verh Dtsch Ges Pathol; 2005; 89():144-54. PubMed ID: 18035684
[TBL] [Abstract][Full Text] [Related]
13. Liver biopsy sampling in chronic viral hepatitis.
Guido M; Rugge M
Semin Liver Dis; 2004 Feb; 24(1):89-97. PubMed ID: 15085489
[TBL] [Abstract][Full Text] [Related]
14. Ethics related to liver biopsies and antiviral therapies in chronic viral hepatitis.
Papatheodoridis GV
Dig Dis; 2008; 26(1):59-65. PubMed ID: 18600018
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
Yokoi Y; Suzuki S; Baba S; Inaba K; Konno H; Nakamura S
J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and histologic surveillance of hepatitis C].
Bralet MP; Zafrani ES
Rev Prat; 2000 May; 50(10):1078-82. PubMed ID: 10905092
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
Lackner C
Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):223-31. PubMed ID: 21476917
[TBL] [Abstract][Full Text] [Related]
18. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
[TBL] [Abstract][Full Text] [Related]
19. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
[TBL] [Abstract][Full Text] [Related]
20. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
